Epicardial cell activation as a paradigm shift in cardiac repair and regeneration
Stem Cells Translational Medicine · 2026
DOI: 10.1093/stcltm/szaf074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, 2026. Verfasst von Roberto Vanni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, University of Turin, Turin 10043, Italy. Hauptthemen laut MEDLINE: Pericardium, Regeneration, Myocardial Infarction, Heart. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-Next Generation EU-NRRP, European Union—Next Generation EU—NRRP.
Abstract (Originalsprache)
Cardiovascular diseases, particularly myocardial infarction, remain a leading cause of mortality globally, primarily due to the adult heart’s limited regenerative capacity. Recent discoveries have highlighted the epicardium, a mesothelial layer surrounding the heart, as a critical player in cardiac repair and regeneration. During development, the epicardium plays a central role in heart formation by providing progenitor cells, structural components, and paracrine signals. Emerging evidence indicates that this developmental potential can be reactivated in the adult heart following injury. Upon activation, epicardial cells undergo epithelial-to-mesenchymal transition, proliferate, and secrete a range of paracrine factors that influence angiogenesis, inflammation resolution, and extracellular matrix remodeling. This review explores the mechanisms underlying epicardial activation, its contributions to heart development and myocardial repair, and its therapeutic potential. We discuss small molecule modulators, gene therapy, cellular therapies, and biomaterial-based approaches that aim to harness the regenerative capacity of the epicardium. These approaches, which move beyond scar tissue formation to possible regeneration, have the potential to transform the landscape of cardiac regenerative medicine. Despite promising preclinical results, however, challenges such as interindividual variability, incomplete differentiation of epicardial-derived cells, and delivery constraints must be addressed. Advances in single-cell technologies, biomaterial engineering, and translational research are paving the way for personalized and effective epicardium-based therapies. By redefining the role of the epicardium in cardiac biology, epicardial activation offers a novel paradigm for treating ischemic heart disease and heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Biological Sciences, University of Turin, Turin 10043, Italy.
- Department of Surgical Sciences, University of Turin, Turin 10126, Italy.
ORCID-Profile: Roberto Vanni, Raffaella Rastaldo
Förderung
- European Union-Next Generation EU-NRRP
- European Union—Next Generation EU—NRRP
Zitieren
APA
Vanni, R., Aubry, M., Rinaldi, M., Rastaldo, R., & Giachino, C. (2026). Epicardial cell activation as a paradigm shift in cardiac repair and regeneration. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szaf074
Vancouver
Vanni R, Aubry M, Rinaldi M, Rastaldo R, Giachino C. Epicardial cell activation as a paradigm shift in cardiac repair and regeneration. Stem Cells Translational Medicine. 2026. doi:10.1093/stcltm/szaf074
BibTeX
@article{Vanni2026,
author = {Vanni, Roberto and Aubry, Matteo and Rinaldi, Mauro and Rastaldo, Raffaella and Giachino, Claudia},
title = {Epicardial cell activation as a paradigm shift in cardiac repair and regeneration},
journal = {Stem Cells Translational Medicine},
year = {2026},
doi = {10.1093/stcltm/szaf074}
}
EUVIMED